Free Shipping for all orders over $150

CJC-1295 and Weight Loss Research

We are becoming more inclined toward our physical appearance in a world built on how people perceive us and a society driven by social media. Unfortunately, there is no such thing as a quick fix. This has led researchers to explore novel approaches to potentially aid weight loss and muscle growth. This includes investigating hormones like CJC-1295. Is this a valuable potential option? Let’s consider some of the facts and research behind this hormone. What is CJC-1295? CJC-1295 is a synthetic analog of the growth hormone-releasing hormone (GHRH). GHRH stimulates the anterior pituitary to produce and release growth hormone (GH) into the bloodstream of subjects. GH, in turn, stimulates the secretion of insulin-like growth factor (IGF-1) from the liver. How Does CJC-1295 Work Research shows that CJC-1295 peptide injections have the potential to attach to a protein in the blood of subjects. This is called Albumin and it has the potential to boost growth hormone levels. A study found it may be effective in raising levels by 2 to 1 times. The same study showed it could potentially stimulate IGF-1 levels by 1.5 to 3 times in healthy subjects. It is to be noted that CJC-1295 may take about 1 to 4 hours to reach its highest levels in subjects. This means it may be much slower than conventional growth hormone boosters like Ipamorelin. However, CJC-1295 may potentially last much longer in the subjects. [R][R] This longer duration may be a result of the binding to Albumin. Albumin has a longer half-life in the body of test subjects. [R] Benefits of CJC-1295 CJC-1295 and GH Levels Research CJC-1295 and IGF-1 Research CJC-1295 and GH Deficiency Research CJC 1295 and Weight Loss Peptides Research Amplified Metabolism and Energy Findings Research shows that certain peptides may have the ability to signal the pituitary gland to release growth hormone. If this is to be proven it can potentially lead to increases in metabolism. This process might influence how nutrients are absorbed and digested. In future interventions, this could lead to sustained energy levels and reduced fatigue. [R] Decreased Body Fat & Increased Muscle Mass Findings If this research is to be proven, higher metabolism and increased muscle mass will be observed. This in turn may lead to body fat reduction during peptide therapy. A higher daily calorie intake will lead to improved muscle protein building aiding weight loss and a more defined muscular physique in subjects. Why Combine CJC and Ipamorelin in Peptide Therapy? Ipamorelin is closely related to CJC-1295. Ipamorelin is a pentapeptide, which also displays a high GH-releasing potential in vivo and in vitro studies. It is the first GHRP-receptor agonist with a selectivity for GH. The specificity of Ipamorelin makes this compound a very interesting candidate for future clinical development. CJC-1295 and Ipamorelin in their respective research may be effective for growth hormone production. This has led to them being studied synergistically. Growth hormone has the potential to reduce excess fat by blocking lipoprotein lipase (LPL). LPL releases fat from the bloodstream of subjects for storage in fat cells. It may also potentially aid in breaking down stored fat. [R] Frequently Asked Questions Can CJC-1295 aid in fat loss research? Yes, CJC-1295 can be relevant in fat loss research. Research has shown that CJC-1295 has the potential ability to stimulate human growth hormone. This makes it a potential candidate for research into fat loss. Particularly how it may influence metabolic rate, fat metabolism, and muscle maintenance. What is the difference between CJC-1295 and CJC-1295 With DAC? CJC-1295 With DAC is different as it includes an added drug affinity complex (DAC). This has the potential to extend the half-life of the compound in subjects. This also means it has the potential to last longer and have an improved ability to bond with protein compared to regular CJC-1295. Summary Peptide therapy has exploded in the research work for its potential future impact on overall health. It has the potential to aid muscle mass, fat metabolism, energy levels, and much more. This may be achieved as a result of its impact on the increased synthesis of growth hormones.

Read More »

Semaglutide Injection for Weight Loss Research

Researchers are constantly searching for effective and safe weight loss treatments. Obesity has become a global pandemic that certainly needs urgent intervention. According to the World Health Organization, in 2022, 2.5 billion adults aged 18 years and older were overweight. This includes over 890 million adults who were living with obesity and weight-related side effects. [R] This has given rise to the newest anti-obesity medication, semaglutide. As of 2021, it has received approval by the U.S. Food and Drug Administration. As a diabetes medication, it has gained popularity as one of the first compounds approved for chronic weight management. This has highlighted the value of treating obesity as an actual metabolic disease. Not just as a factor of lifestyle changes such as diet and exercise. However, Semaglutide is not for everyone. Here is what you need to know about Semaglutide: What is Semaglutide? Semaglutide is a compound known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). It is mostly known under the brand name Ozempic and has seen a surge in popularity of late under the celebrity community. Its mechanism of action involves mimicking the GLP-1 hormone. This is a natural hormone released in the gastrointestinal tract after meals. GLP-1 plays a pivotal role in stimulating insulin production by the body, thereby lowering blood sugar levels. As a result, healthcare professionals have been employing Semaglutide for over 15 years to manage Type 2 diabetes. [R] Elevated levels of GLP-1 influence the regions in the brain responsible for suppressing appetite. It also triggers feelings of fullness. When combined with a healthy diet and exercise habits, Semaglutide may lead to substantial weight loss. Additionally, it may reduce the risk of conditions such as cancer, diabetes, and heart disease in patients who are overweight or obese. [R] Prescribed Semaglutide for Weight Loss Currently, Semaglutide is approved for weight loss only under the brand name Wegovy. It is mostly administered as a subcutaneous (under the skin of patients) injection. Initially used only as a diabetes medication, it is the first compound since Saxenda (2014) to be approved for chronic weight management.[R] Interest in semaglutide injections for weight loss has grown substantially. Healthcare professionals are constantly finding ways to meet the demand. Many are prescribing other Semaglutide brands, such as Ozempic and Rybelsus. These are off-label (using the drug for a purpose not originally approved by the FDA) alternatives. How Does Semaglutide Work? As mentioned above, Semaglutide is a GLP-1 receptor agonist and has the potential to occupy the GLP-1 receptor in the brain. This is the receptor responsible for regulating appetite. [R] GLP-1 has effects on weight loss in 2 potential ways: Research Supporting Semaglutide for Weight Loss Clinical and STEP trials have highlighted Semaglutide’s role in promoting weight loss. In test subjects with obesity or overweight users with type 2 diabetes substantial weight loss was observed. [R] This benefit is thought to result from its impact on appetite regulation. Slow gastric emptying, and increased feelings of fullness, may inhibit food intake as supported by this research. [R] To learn more about Semaglutide and other weight loss medications, reach out to your primary care physician or health care expert. What are the side effects of semaglutide injections in subjects? The side effects of Semaglutide in preliminary research are rather mild. The most common complaint by subjects is gastrointestinal discomfort. However, this has been negated by starting on lower doses. Additional side effects in studies may include dizziness, fatigue, headaches, and stomach problems. [R] Where to Buy Semaglutide? BC9 offers Semaglutide in a 5mg and 10mg peptide vial. However, it is important to note that BC9 sells Semaglutide for research purposes only and it is not intended for human consumption. Frequently Asked Questions Is Semaglutide the same compound as Ozempic and Wegovy? Yes, Semaglutide is the active compound in both Ozempic and Wegovy. Although they contain the same active ingredient, the difference between the two lies in their approved uses and dosages. Could Semaglutide be effective for chronic weight management? Clinical trials have demonstrated that Semaglutide may lead to significant weight loss. Especially when combined with lifestyle factors such as diet and exercise. This makes it a potentially valuable option for those seeking chronic weight management. What are the brand names for Semaglutide? Semaglutide is marketed under the brand names Wegovy for weight loss management and Ozempic for type 2 diabetes. Final Thoughts Semaglutide’s diverse benefits make it valuable for diabetes treatment. It also offers significant potential for weight loss management.

Read More »
Wishlist 0
Continue Shopping
X
Add to cart

Notifications

Products On Sale

We are offering the following products on sale. Hurry up before the sale ends!